Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19596,138,1.48 [0.87-2.53],0.1467400972335089
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20442,155,0.90 [0.52-1.53],0.6857748911764818
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20232,1167,1.32 [1.09-1.60],0.0036976656941403
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,20450,311,1.92 [1.38-2.68],0.0001120011587072
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19852,2900,1.21 [1.07-1.37],0.0022139360472047
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19840,2936,1.32 [1.17-1.49],4.226828475846365e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,20272,884,1.04 [0.83-1.30],0.7310204848672828
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,20394,69,1.25 [0.57-2.71],0.5784467001626088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18561,911,1.42 [1.15-1.75],0.0012515186482129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17892,996,1.29 [1.05-1.59],0.0158645038642352
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17715,207,1.84 [1.22-2.76],0.0034073956112257
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14398,1905,1.28 [1.11-1.49],0.0009751016094036
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17656,336,1.42 [1.01-2.01],0.0452042719607259
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20443,1055,1.04 [0.85-1.28],0.7054784519271826
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,20527,388,1.87 [1.38-2.52],4.609672763654576e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19795,730,1.27 [1.00-1.61],0.0537348649397292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20465,1007,1.40 [1.14-1.71],0.0011112083942031
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19545,157,0.87 [0.51-1.48],0.6062610545402892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20562,42,1.03 [0.37-2.89],0.95451738074681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,20332,874,1.39 [1.12-1.72],0.002870668562898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20378,53,0.73 [0.29-1.83],0.5045621641906204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20502,99,1.87 [1.03-3.39],0.0406092266196788
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20488,85,1.92 [1.01-3.67],0.0467944069499106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19465,400,1.49 [1.08-2.04],0.0141022147035693
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,19306,241,1.12 [0.73-1.70],0.6133592780068651
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19456,68,1.35 [0.62-2.96],0.4476077023876628
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20543,59,1.07 [0.45-2.51],0.8795956857390738
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20512,126,1.43 [0.81-2.55],0.2176280129851919
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral warts,20432,46,1.23 [0.46-3.25],0.6784712899790388
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20432,46,1.82 [0.75-4.41],0.1857915931736888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm,20297,300,1.04 [0.71-1.54],0.8306708238115519
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20503,43,0.78 [0.28-2.22],0.6445822369051966
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20467,50,1.06 [0.41-2.75],0.8966254970588604
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20524,107,1.23 [0.64-2.35],0.5302154681047124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",20241,1413,0.82 [0.68-0.98],0.0309938193737079
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of meninges,20561,26,0.66 [0.18-2.51],0.5463194904999673
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20508,59,1.35 [0.58-3.15],0.4840732250843741
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20548,66,0.63 [0.27-1.45],0.2779268568417452
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20539,392,0.87 [0.62-1.22],0.4176188581441423
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Caecum,20541,294,0.97 [0.66-1.43],0.8777471771472204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20452,65,0.59 [0.25-1.37],0.2201332943056323
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,20536,248,0.75 [0.48-1.15],0.1825119039276965
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Rectum,20499,367,0.86 [0.60-1.23],0.4145768144752261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20455,636,0.92 [0.70-1.20],0.5324893326646862
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20525,474,0.86 [0.63-1.17],0.3493420064647504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16007,62,1.28 [0.57-2.91],0.5505604029598568
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16005,60,1.48 [0.66-3.29],0.3386889331944666
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20532,79,1.89 [0.97-3.67],0.0606887057312953
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma, any site",20532,76,1.87 [0.95-3.69],0.0707309259760492
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,13718,306,1.73 [1.18-2.53],0.0047549072942507
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lymphoid leukaemia,16002,57,1.21 [0.51-2.88],0.670118417786369
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16113,168,1.10 [0.65-1.83],0.7293569295932143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16189,244,1.08 [0.71-1.66],0.7120981460930751
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16026,81,0.75 [0.36-1.58],0.4536142009651341
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16061,116,0.66 [0.35-1.24],0.1929352691703281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16073,128,1.18 [0.66-2.09],0.5758826035370727
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16014,69,0.86 [0.39-1.93],0.7175651773640354
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17129,1184,0.85 [0.70-1.03],0.1029814064417605
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16073,128,1.05 [0.58-1.90],0.8622174020763896
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16039,94,0.92 [0.46-1.83],0.8100761560266146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16050,105,1.35 [0.71-2.56],0.3582327599476462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi,20459,147,0.81 [0.46-1.43],0.4678424613961985
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi of trunk,20535,85,0.92 [0.44-1.93],0.8291178581431197
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanoma in situ,15975,64,0.88 [0.38-2.07],0.7701741387574927
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16032,87,1.73 [0.93-3.25],0.0853630578496733
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16089,144,1.31 [0.77-2.23],0.3212094848275427
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16142,197,1.34 [0.85-2.12],0.2076905227114409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16035,90,1.56 [0.83-2.90],0.1651028376937721
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Other benign neoplasms of skin,20448,125,1.15 [0.64-2.09],0.6331470412934541
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16973,1028,1.04 [0.84-1.28],0.7065400385784599
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17035,1090,1.07 [0.88-1.32],0.4924189158486953
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,20329,251,1.43 [0.95-2.14],0.0834231789160381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,19115,68,0.92 [0.41-2.08],0.8463225283915379
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,20136,58,1.67 [0.75-3.71],0.2075421920166988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20118,2323,1.10 [0.96-1.26],0.174501725641906
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19518,54,1.57 [0.70-3.53],0.2741235253894449
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,20200,43,1.32 [0.49-3.53],0.5870408186572136
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20272,1225,1.07 [0.89-1.29],0.4856790926719843
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20270,1223,1.07 [0.88-1.29],0.489744873491085
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,19126,79,1.04 [0.49-2.22],0.9106073622773851
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,20373,909,1.02 [0.82-1.27],0.8762425317327212
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,20250,93,1.20 [0.61-2.38],0.601151122152374
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,20140,62,1.99 [0.96-4.16],0.0659072945473383
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,20134,56,1.47 [0.62-3.46],0.3804424344933543
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20419,262,1.56 [1.06-2.28],0.0233094297094679
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20479,39,1.05 [0.36-3.08],0.9241860308074644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",20370,213,1.52 [0.99-2.32],0.0555855025899988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19526,62,0.70 [0.30-1.63],0.4024338081633685
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15240,308,1.67 [1.20-2.33],0.0021705477599891
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18790,137,1.34 [0.77-2.34],0.3001001042562611
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18821,168,1.97 [1.27-3.05],0.0026207258509973
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14981,49,2.29 [1.14-4.63],0.020698357041391
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,19411,52,2.18 [0.99-4.77],0.051598774511296
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18753,186,1.35 [0.84-2.16],0.2189368692398975
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",20168,485,1.36 [1.02-1.82],0.0348459395737993
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19883,200,1.35 [0.86-2.12],0.1919011484229772
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19802,119,0.91 [0.49-1.69],0.7584515674592784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,20307,948,1.06 [0.85-1.31],0.6127836864356401
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17636,916,1.11 [0.89-1.39],0.3506726610615713
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14994,62,1.32 [0.60-2.92],0.4911176213907455
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19843,36,0.47 [0.15-1.43],0.1819911960050667
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15154,222,1.08 [0.69-1.69],0.7294984279304644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14994,62,2.29 [1.24-4.23],0.0078628308296095
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18242,3310,1.02 [0.91-1.15],0.6790822376993515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15088,156,1.58 [0.98-2.55],0.0580899373373848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15401,469,1.34 [1.00-1.79],0.0488037871332058
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20514,225,1.33 [0.86-2.04],0.1960260010626246
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,20359,70,0.63 [0.28-1.44],0.2770237916892749
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15062,130,1.41 [0.81-2.44],0.2193247967231872
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14986,54,0.83 [0.34-2.06],0.691197720225063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20408,601,1.04 [0.79-1.37],0.768058310395041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15181,249,1.60 [1.11-2.30],0.0119614862547413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15225,293,1.27 [0.88-1.83],0.2066881611526222
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15548,616,1.14 [0.88-1.48],0.3356884953684293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15048,116,1.20 [0.67-2.17],0.5413657035096407
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,20354,65,0.77 [0.33-1.80],0.5485221577426032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15424,492,1.56 [1.19-2.05],0.0013417391241503
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15277,345,1.52 [1.10-2.10],0.0116740931064991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18615,48,1.59 [0.63-4.01],0.3234895036897404
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19385,4453,1.12 [1.01-1.23],0.0305154230792586
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19818,11,2.36 [0.52-10.78],0.2676979771959759
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19828,21,0.79 [0.43-1.45],0.4496432798289432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20423,1519,1.13 [0.95-1.33],0.1644728305379271
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20419,1514,1.12 [0.95-1.32],0.1929343045290825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19819,12,2.16 [0.41-11.49],0.3670154494309567
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,20333,696,1.31 [1.02-1.68],0.036097406795848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16296,1364,1.46 [1.24-1.72],8.254080740794466e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20553,205,1.96 [1.32-2.89],0.0007464938970109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19770,87,1.35 [0.68-2.69],0.3905229257897623
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19701,64,1.25 [0.55-2.82],0.5959283778393255
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19709,72,0.75 [0.34-1.67],0.4846168515283834
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14990,58,0.62 [0.25-1.54],0.3030380025469115
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,18169,144,2.12 [1.40-3.22],0.0004110578255595
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2168,106,1.24 [0.65-2.37],0.5116404528257774
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2304,270,0.74 [0.49-1.11],0.1427729626204897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,18107,82,1.09 [0.54-2.22],0.8052294262104738
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2122,60,0.69 [0.29-1.65],0.409322275692161
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19913,1888,1.34 [1.16-1.54],5.329815475116685e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19958,275,1.11 [0.75-1.66],0.6002863020913645
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18769,202,1.35 [0.86-2.13],0.1904471991269177
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15583,651,1.21 [0.95-1.56],0.1283345878058308
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20451,207,1.65 [1.06-2.58],0.0261964161291883
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19541,236,1.17 [0.76-1.79],0.485041774729803
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Angina pectoris,18096,1266,1.30 [1.09-1.56],0.0037872500325971
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19638,333,1.17 [0.82-1.68],0.3915921065765718
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,19372,67,2.47 [1.31-4.64],0.0050976833468675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19500,195,2.14 [1.47-3.13],8.218083951550643e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12042,1950,1.34 [1.15-1.58],0.0002643860472151
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,AV-block,16601,512,0.94 [0.70-1.27],0.6831702328401206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20504,445,0.94 [0.68-1.29],0.6945559632892975
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,10306,214,2.80 [1.75-4.50],1.9501312759343084e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16263,174,1.29 [0.78-2.11],0.3174011868611619
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16183,94,0.96 [0.48-1.95],0.9199982485785124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20563,50,2.13 [0.97-4.68],0.059275959020133
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Conduction disorders,17234,1145,1.04 [0.85-1.27],0.7016543958457365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19062,2253,1.19 [1.04-1.37],0.0119967289534728
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17415,6742,1.08 [1.00-1.18],0.0546298625557062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19505,228,1.56 [1.02-2.39],0.0413201837918977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Endocarditis,16160,71,1.33 [0.62-2.87],0.4599696821407719
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",20291,1128,1.41 [1.17-1.69],0.0003307806877944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertension,18431,5851,1.05 [0.96-1.15],0.2613086129327256
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18436,5856,1.05 [0.96-1.15],0.2727131428844747
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20365,98,2.22 [1.31-3.76],0.0028935145617414
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12750,170,3.07 [2.37-3.99],2.853139280100169e-17
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12681,101,1.14 [0.60-2.18],0.6938498896679473
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,20438,1016,1.59 [1.30-1.93],4.106700376283104e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19665,97,1.08 [0.55-2.12],0.8298951306707557
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19182,2352,1.15 [1.01-1.32],0.0369905903423205
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",20214,558,1.20 [0.91-1.58],0.2048967715458137
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16438,349,1.29 [0.91-1.82],0.1573390093050565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19966,915,1.07 [0.86-1.33],0.5492826811600374
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17622,792,1.08 [0.85-1.36],0.5345248147694084
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20425,197,1.14 [0.71-1.82],0.5916485903448397
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20519,325,1.14 [0.79-1.65],0.4769103543179913
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,19333,56,2.21 [0.99-4.95],0.0532391199143159
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other aneurysm,19383,78,2.26 [1.23-4.16],0.0089101532944307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,16503,414,1.34 [0.98-1.84],0.0680381374449139
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,19413,108,2.48 [1.51-4.05],0.0003086782018618
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19536,231,1.10 [0.71-1.71],0.6729538380194182
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16250,161,1.96 [1.25-3.05],0.0030599685187828
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,19353,76,2.25 [1.13-4.47],0.0203451686984529
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,19320,43,0.40 [0.14-1.12],0.0805855324232754
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,19235,78,0.92 [0.43-1.97],0.8336447362145274
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,19366,89,1.23 [0.61-2.47],0.56387099793892
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17139,1050,1.32 [1.08-1.60],0.0066063639908457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19477,55,1.76 [0.78-3.99],0.1731743094313136
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19777,472,1.68 [1.27-2.22],0.0002694862009069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,20010,318,2.76 [2.17-3.50],7.547468311674883e-17
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19711,554,1.18 [0.89-1.56],0.2409071019282536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10404,312,2.00 [1.35-2.97],0.000565262932409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19694,431,1.85 [1.40-2.44],1.3581812850398452e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19569,292,1.52 [1.04-2.22],0.0293865222919362
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,20109,417,1.03 [0.75-1.43],0.8486506370225294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20507,596,1.39 [1.07-1.80],0.0127055245281946
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16493,404,1.08 [0.78-1.51],0.633885567065062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,20009,317,2.74 [2.16-3.48],1.5767681001434343e-16
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,19340,183,1.48 [0.93-2.35],0.0972523653678155
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",20199,631,1.15 [0.88-1.49],0.3023369297997603
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",20188,656,1.12 [0.87-1.45],0.3856880715375508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19650,39,0.77 [0.26-2.31],0.6391394855014474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,19401,97,1.06 [0.53-2.12],0.8597492970973355
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19856,200,1.11 [0.70-1.77],0.6624628365182395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,19316,265,1.24 [0.84-1.84],0.2839967184800129
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Varicose veins,19606,329,1.35 [0.93-1.94],0.1101674252212038
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,19321,63,1.76 [0.82-3.76],0.1473082308379477
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,20347,649,1.14 [0.88-1.48],0.3180903720684075
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20385,427,1.21 [0.88-1.66],0.2478081206672205
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17728,837,1.27 [1.01-1.59],0.043249883204119
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,19964,3073,1.17 [1.04-1.32],0.0113486237874023
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20329,496,1.17 [0.87-1.57],0.3136387113262379
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17872,981,1.14 [0.92-1.41],0.2241019779732716
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16955,64,1.67 [0.76-3.65],0.199269526317696
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,19993,1328,1.31 [1.09-1.57],0.0032448671187852
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18494,1603,1.24 [1.05-1.48],0.0130329455951033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Vascular dementia,20170,123,1.69 [1.01-2.85],0.0475024996762219
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,20562,251,1.36 [0.91-2.03],0.1373934443857158
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13771,49,2.26 [1.21-4.21],0.0106510846494457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,19379,69,2.30 [1.19-4.47],0.0137684115386225
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19609,299,1.08 [0.74-1.59],0.6856199811632581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral cysts,20219,197,1.15 [0.71-1.85],0.5695382896784593
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20485,289,0.96 [0.65-1.43],0.8414542174559528
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,20149,56,0.68 [0.27-1.70],0.4054442275460599
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20546,66,1.63 [0.77-3.44],0.1998471371025452
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",20097,75,2.53 [1.36-4.70],0.0032351088183683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,19192,237,1.57 [1.04-2.37],0.0323117868580286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,20110,1155,1.12 [0.93-1.36],0.2425725258915787
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20529,405,0.90 [0.64-1.26],0.5214998101461377
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,20085,1823,1.40 [1.20-1.63],1.4084325683457465e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,20237,51,3.33 [1.69-6.56],0.0005210723421939
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hemiplegia,20419,223,0.97 [0.62-1.51],0.8810325758435191
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hydrocephalus,20069,47,1.50 [0.59-3.84],0.3964219640593325
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20546,51,1.80 [0.76-4.26],0.1818013798935486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,19330,20,1.78 [0.44-7.21],0.4168585162023854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,19391,81,1.26 [0.61-2.61],0.5261731958260774
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Memory loss,20032,104,1.67 [0.91-3.06],0.0956024715816977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Migraine,19120,165,1.25 [0.74-2.10],0.4097969267661937
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20542,150,1.38 [0.80-2.37],0.2472475063098005
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Motor neuron disease,13875,141,1.28 [0.73-2.23],0.3913395349242219
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20462,58,1.34 [0.56-3.22],0.5124578214927181
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",20146,836,1.25 [1.00-1.57],0.0524355123029715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,19419,3027,1.09 [0.97-1.24],0.1473359423680195
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,20280,187,0.93 [0.57-1.52],0.7703988181283516
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19627,317,1.25 [0.86-1.80],0.2415094955652187
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20484,297,1.85 [1.33-2.58],0.0002813193191572
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16240,520,1.24 [0.93-1.66],0.1354929883699481
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,20085,63,0.43 [0.18-1.01],0.0531114403028904
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,20150,128,1.47 [0.85-2.54],0.1708548904920462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,20234,110,1.14 [0.61-2.16],0.6777747344771241
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,19396,86,1.64 [0.84-3.21],0.1443584595919505
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other headache syndromes,18989,34,0.98 [0.31-3.11],0.9711828317762192
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other neurological diseases,20461,439,1.06 [0.77-1.46],0.7082298222402057
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other sleep disorders,19553,598,0.98 [0.75-1.28],0.8778654767503108
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Parkinson's disease,20541,277,0.80 [0.53-1.21],0.29859060560485
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,20045,23,0.31 [0.08-1.27],0.1034355462040387
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,20561,36,1.80 [0.67-4.83],0.2435626420221138
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Sleep apnoea,20309,540,0.97 [0.73-1.28],0.8391579022508797
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,20236,49,2.47 [1.21-5.04],0.0130979254738726
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20545,162,1.44 [0.86-2.40],0.1657388659537597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,19339,29,0.99 [0.28-3.46],0.9863643775088852
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20562,254,1.35 [0.90-2.01],0.1460407564760837
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),20142,119,1.66 [0.98-2.84],0.0613830842795109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,20106,73,1.83 [0.91-3.68],0.08932146080155
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,20267,247,0.96 [0.63-1.46],0.8397650991883018
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,20408,251,1.19 [0.80-1.77],0.3919378752073134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19804,38,2.28 [1.03-5.07],0.0431316091932796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19821,55,2.23 [1.03-4.84],0.0427065519135348
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20484,35,1.86 [0.69-5.02],0.2181116549710657
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,20369,103,1.63 [0.89-3.00],0.1129160157521251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2122,60,0.81 [0.34-1.93],0.637884873826376
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2584,111,1.33 [0.71-2.47],0.3755083539100236
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,20114,81,1.30 [0.63-2.69],0.4788446124926946
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,20368,854,1.01 [0.81-1.27],0.8983361891621536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",20296,530,1.11 [0.84-1.48],0.4586147283540216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19883,117,1.05 [0.57-1.95],0.8654412281888888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20499,479,0.90 [0.66-1.22],0.4869503513991334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20560,55,1.21 [0.50-2.93],0.6777485728043593
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20444,424,0.86 [0.62-1.19],0.3609232843251697
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20529,263,1.23 [0.82-1.83],0.3175665803553356
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20484,132,0.67 [0.37-1.21],0.1822463573169715
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19833,67,0.63 [0.27-1.46],0.2819358885146376
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19840,74,1.85 [0.94-3.64],0.0762328134850169
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19800,34,1.01 [0.32-3.14],0.9916271609161472
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20481,585,1.11 [0.84-1.46],0.4637290813244229
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,20064,168,1.15 [0.69-1.92],0.5795319629392515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,20044,24,0.69 [0.17-2.79],0.6029986579066802
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,20347,81,1.46 [0.72-2.94],0.2924720822798349
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20452,186,1.30 [0.81-2.09],0.2789106754856588
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,20169,149,0.67 [0.38-1.18],0.1656146547666523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,20422,70,0.51 [0.23-1.16],0.1098699049318469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,20277,381,1.15 [0.82-1.61],0.4212586228415278
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,20134,101,0.92 [0.47-1.80],0.819134018166727
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,19412,1524,1.09 [0.92-1.29],0.3101452754267338
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20428,162,1.25 [0.75-2.09],0.3908212951665529
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20548,122,1.60 [0.92-2.79],0.0955762052818909
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,20131,365,1.07 [0.75-1.51],0.7144925221551701
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,20323,57,2.12 [1.00-4.48],0.049021268618685
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20551,46,1.00 [0.37-2.68],0.9985806033332776
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19828,62,0.58 [0.24-1.40],0.2262584003159171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19895,129,0.72 [0.40-1.31],0.2849685652685957
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19620,106,1.13 [0.60-2.13],0.7019265935308157
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,20060,40,1.31 [0.46-3.70],0.6104064938387624
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19570,56,1.11 [0.45-2.76],0.8152414069238988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19939,43,1.36 [0.50-3.74],0.5504234056347386
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",20067,171,1.02 [0.62-1.70],0.9258190640504276
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19858,92,1.19 [0.60-2.34],0.6177100594770175
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19622,108,1.14 [0.59-2.20],0.6967304549590851
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19592,78,0.62 [0.29-1.33],0.2200121587747292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19117,1229,1.18 [0.98-1.42],0.0806634176370712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19814,48,1.08 [0.41-2.79],0.8805383647054856
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,20355,322,1.07 [0.73-1.55],0.7373744621198867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,20092,59,0.48 [0.20-1.15],0.0995999360399098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),20163,130,1.61 [0.93-2.79],0.0859440697366585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,20400,53,1.20 [0.48-3.00],0.6909766170896532
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20526,103,1.06 [0.54-2.05],0.8678168282135899
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20445,99,1.93 [1.06-3.52],0.0315807729638817
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,20394,47,2.96 [1.49-5.90],0.0019821928939921
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,20394,47,1.02 [0.38-2.72],0.97210764343683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20476,799,1.10 [0.87-1.39],0.4344120763913239
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,20272,595,1.03 [0.78-1.35],0.851026190738049
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19789,112,0.99 [0.53-1.86],0.979009108853348
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19748,71,1.40 [0.65-3.00],0.3909750174116718
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,20374,48,1.68 [0.68-4.16],0.2584259290455003
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20487,161,1.52 [0.92-2.50],0.1014305294443331
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20379,53,2.27 [1.08-4.76],0.0306660172165525
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza,18640,86,1.23 [0.60-2.50],0.5702743714029229
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18637,83,1.33 [0.65-2.71],0.4402701834629917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13503,91,0.77 [0.37-1.59],0.4797636230635236
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,20474,236,1.04 [0.67-1.61],0.8577729958793585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14356,1243,1.03 [0.85-1.25],0.7818567408217452
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14630,1218,1.02 [0.84-1.24],0.8560375757068382
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),20223,125,1.97 [1.20-3.26],0.0077841430581663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18630,76,2.56 [1.51-4.35],0.0004707970766351
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bronchiectasis,17854,249,0.96 [0.63-1.46],0.8391114591308633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17642,37,1.59 [0.58-4.36],0.3633424087403988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19820,2215,1.16 [1.00-1.33],0.0424577822829407
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19304,70,1.19 [0.54-2.65],0.6635068330852303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,19370,136,1.12 [0.63-1.99],0.6966242240722489
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",20370,1126,1.25 [1.03-1.52],0.0229788406514022
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,19362,128,1.37 [0.76-2.44],0.2921220948064507
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18817,4508,1.22 [1.11-1.35],5.844253065047948e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19580,346,1.02 [0.71-1.46],0.923755739379219
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,19523,279,1.64 [1.14-2.38],0.0083491714738281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Emphysema,17920,315,1.74 [1.25-2.41],0.0010530457767324
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19747,307,2.88 [2.28-3.63],4.790260282241256e-19
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20349,1795,1.46 [1.25-1.69],8.294383024089385e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,19769,329,2.72 [2.15-3.45],1.3298800433413802e-16
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Later onset COPD,19608,847,1.12 [0.90-1.40],0.3133261694228484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20545,336,1.03 [0.72-1.49],0.8632884759133364
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Nasal polyp,19366,132,1.04 [0.58-1.88],0.8925876285309484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,20322,826,1.75 [1.42-2.17],1.6035014220009638e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,20319,1875,1.36 [1.18-1.58],4.082647749590853e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19997,763,1.02 [0.80-1.31],0.846818639902668
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other pleural conditions,18497,53,2.77 [1.52-5.05],0.0008901647078116
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20468,403,2.63 [2.10-3.29],3.818975345516461e-17
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20453,1197,1.22 [1.01-1.47],0.0431674980267375
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,19384,940,1.44 [1.17-1.77],0.0006558685078866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural plaque,18674,230,1.67 [1.13-2.48],0.0105585215164205
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20128,1574,1.49 [1.27-1.74],1.0405428560190115e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20456,247,1.08 [0.71-1.65],0.7216086067151334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,18566,122,1.08 [0.58-2.00],0.8102356396193451
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pollen allergy,20547,203,1.12 [0.70-1.80],0.6229849014953954
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,20125,60,3.38 [2.05-5.57],1.7596539339470133e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13461,49,1.57 [0.65-3.81],0.3199599428786523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,20305,809,1.74 [1.41-2.16],3.167012099368115e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19471,237,1.04 [0.67-1.61],0.8575101103495845
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Viral pneumonia,18786,232,1.30 [0.85-1.98],0.2191947188701213
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",20242,198,1.12 [0.70-1.78],0.6389911286143981
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,9022,99,1.08 [0.54-2.15],0.8299121864731172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14410,76,1.10 [0.52-2.32],0.809251805904226
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute appendicitis,20448,125,0.71 [0.38-1.32],0.2753412672171761
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute gastritis,15584,73,1.03 [0.47-2.26],0.9345767969185264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,19404,177,1.42 [0.88-2.31],0.1546350223576185
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute peritonitis,20247,80,1.64 [0.83-3.24],0.1580798625339865
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19787,96,3.33 [2.08-5.32],5.304321086777617e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,15957,446,0.93 [0.67-1.28],0.6468059457254607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",19332,105,0.66 [0.34-1.28],0.2145032191413124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",20210,105,0.64 [0.33-1.25],0.1958903183501409
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholecystitis,19413,186,1.41 [0.88-2.27],0.1520527391887124
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholelithiasis,19912,685,1.20 [0.93-1.54],0.1533670675212893
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic gastritis,15732,221,1.18 [0.75-1.84],0.474070790838255
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,19277,50,1.79 [0.74-4.30],0.1943779368734392
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20387,120,2.00 [1.21-3.33],0.0072932099875395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Coeliac disease,19149,79,0.90 [0.41-1.94],0.7833588275843437
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Collagenous colitis,19320,41,1.97 [0.78-4.95],0.1497102624567818
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20411,190,0.99 [0.61-1.59],0.9514747439454696
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,20420,1315,1.00 [0.83-1.20],0.9978999370529312
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn disease,19358,79,1.04 [0.49-2.22],0.921872324724122
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",20264,58,0.77 [0.31-1.89],0.5657232283873261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,19345,66,1.24 [0.55-2.81],0.6027380191716101
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Dental caries,20013,191,1.21 [0.75-1.93],0.433475241293596
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17426,1663,1.04 [0.88-1.23],0.6145247484006248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of appendix,20474,151,0.73 [0.42-1.29],0.2796688445298285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,20443,752,1.42 [1.13-1.80],0.0029423838812441
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18839,3328,1.18 [1.05-1.32],0.0057847316873058
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",20250,428,1.33 [0.97-1.82],0.072199556495808
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20522,355,1.10 [0.77-1.56],0.6029397071646286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19912,90,1.42 [0.72-2.78],0.3113438417372034
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19799,51,0.71 [0.27-1.83],0.4763630732421925
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,20292,1222,1.11 [0.92-1.35],0.2649557930082032
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of tongue,19809,98,0.80 [0.40-1.59],0.5193646003472632
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",20261,1034,1.26 [1.03-1.54],0.0268430547288433
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16975,2641,0.84 [0.74-0.96],0.0116899869243681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,15729,218,1.30 [0.83-2.05],0.2571901229949981
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20458,168,1.52 [0.94-2.46],0.0870859988965706
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20501,36,1.16 [0.39-3.52],0.7869231878477061
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19830,139,1.94 [1.19-3.16],0.0075294033748563
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14486,152,1.00 [0.59-1.70],0.999997108901017
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,15867,356,1.01 [0.71-1.45],0.9391848842875988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastric ulcer,15822,311,1.25 [0.86-1.82],0.2500060891900555
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,17347,1836,1.13 [0.97-1.32],0.1223695637368983
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16009,498,1.24 [0.92-1.67],0.1560994814581365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15743,6865,1.05 [0.97-1.14],0.219747779138951
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,GI-bleeding,20081,1011,1.13 [0.92-1.39],0.2383950069212126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19867,45,0.67 [0.24-1.84],0.4383946713814033
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15142,1047,0.88 [0.72-1.09],0.2363121040274692
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19763,72,2.83 [1.63-4.89],0.0002081715238777
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Hernia,18787,3024,1.01 [0.89-1.14],0.9221678610467736
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impacted teeth,20504,35,1.35 [0.45-4.08],0.5931271687983064
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impaction of intestines,14372,38,1.38 [0.49-3.92],0.5422111641008873
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Inguinal hernia,17165,1402,0.96 [0.80-1.16],0.6941625083536134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15931,168,1.01 [0.59-1.72],0.9765461119439882
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14413,79,1.01 [0.48-2.14],0.9768528975600096
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,19162,92,0.86 [0.42-1.75],0.6694923202007976
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14578,244,1.40 [0.93-2.11],0.1054423503740575
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20525,324,1.20 [0.84-1.73],0.3151332466049106
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19857,578,1.24 [0.94-1.62],0.1226930597580233
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,20041,762,1.27 [1.00-1.61],0.0485587019635418
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15696,185,1.73 [1.07-2.81],0.0257737032296249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,16051,540,1.45 [1.10-1.92],0.0093239211680347
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20514,96,1.16 [0.58-2.30],0.6783267784083953
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15826,63,0.59 [0.25-1.41],0.2356735653243639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15578,1244,1.06 [0.88-1.28],0.5331238750355054
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,19448,221,1.02 [0.65-1.60],0.9422242112610876
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,19330,103,1.06 [0.55-2.06],0.8601139547943599
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,15972,1638,0.91 [0.77-1.08],0.2947391138210536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,19004,4670,0.96 [0.87-1.06],0.422695843309366
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19780,156,1.02 [0.59-1.75],0.9536135926102456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,20295,604,1.37 [1.05-1.77],0.0191373848956123
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16135,624,1.01 [0.77-1.33],0.9244713332332724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,19341,114,0.91 [0.49-1.72],0.7826559768706641
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20466,299,0.99 [0.67-1.46],0.9681290631438992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16187,676,1.14 [0.88-1.48],0.3150515248900493
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,20090,1020,1.12 [0.91-1.38],0.2700851668077583
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19970,148,1.03 [0.60-1.78],0.9050397837277632
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15680,1346,0.99 [0.82-1.18],0.8772246005196866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17108,1597,1.15 [0.97-1.36],0.0985950547250115
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19771,80,1.20 [0.58-2.48],0.614184641664016
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19943,664,1.33 [1.03-1.71],0.0265491436664228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14630,296,1.19 [0.82-1.74],0.3650785296677303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20492,44,1.06 [0.39-2.91],0.9052507887526462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14740,406,1.10 [0.79-1.53],0.5622597062117118
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",19215,145,1.23 [0.71-2.13],0.4617624071486916
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20549,36,1.04 [0.34-3.16],0.9433592415476912
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19828,86,1.63 [0.82-3.24],0.167098969018053
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Toxic colitis,19319,40,2.79 [1.34-5.79],0.0058711222923312
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15770,259,1.40 [0.93-2.12],0.1086341334691844
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,19407,128,1.17 [0.65-2.11],0.5992680592205506
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19385,106,1.56 [0.84-2.89],0.1587973239252076
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Umbilical hernia,16076,313,0.63 [0.43-0.92],0.0167847873486614
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14469,135,1.17 [0.67-2.04],0.5847959209731644
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ventral hernia,15985,222,1.32 [0.85-2.06],0.2200535573274714
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Volvulus,14396,62,0.71 [0.30-1.69],0.4449099339928712
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20507,274,1.51 [1.03-2.21],0.0339898207207597
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,20296,61,1.22 [0.53-2.83],0.6382456732914527
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18880,81,2.79 [1.71-4.54],4.070761484053779e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19925,646,1.34 [1.04-1.72],0.0241543036947678
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19452,173,1.17 [0.71-1.93],0.5358022433012752
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,19175,376,1.87 [1.40-2.51],2.7627677353414072e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,20311,234,1.33 [0.88-2.03],0.1797816331958426
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20480,403,1.12 [0.81-1.56],0.4824149833263128
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,20116,39,0.40 [0.13-1.20],0.101909025775821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19271,2693,1.30 [1.14-1.47],5.6032740945361376e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,20164,341,1.30 [0.91-1.85],0.1455583195285544
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,20065,242,1.03 [0.67-1.58],0.8913636687656772
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,20156,877,1.39 [1.12-1.73],0.0026078092270525
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20552,25,2.20 [0.75-6.45],0.1510385384426346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18822,23,0.38 [0.09-1.53],0.1727549360824642
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19874,51,2.15 [1.04-4.43],0.0384835164796167
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,20307,230,1.34 [0.88-2.05],0.1705594167169887
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,19215,416,1.25 [0.90-1.73],0.1764788480054134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18864,65,2.14 [1.08-4.24],0.0300177624064855
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20505,70,0.97 [0.44-2.17],0.9432509568877572
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19450,171,1.76 [1.11-2.79],0.016810774089883
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,20415,180,1.17 [0.71-1.92],0.5309903015232065
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,20134,57,0.91 [0.37-2.21],0.8318482186826472
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18853,54,0.73 [0.29-1.88],0.5152879493637498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20170,1371,1.51 [1.27-1.79],2.17141257461313e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",19252,453,1.27 [0.93-1.72],0.1339524264456675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18867,68,2.05 [1.03-4.08],0.042045870495968
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20486,251,1.18 [0.78-1.79],0.439723265670491
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,20123,46,1.97 [0.86-4.55],0.1107000582771318
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20455,220,1.08 [0.68-1.69],0.7513761731980833
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20522,289,1.59 [1.10-2.28],0.0132243112848236
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18876,77,2.58 [1.50-4.43],0.0005909242036264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,19028,229,0.97 [0.62-1.53],0.9069969029954228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20517,284,1.57 [1.08-2.27],0.0174757429001824
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",19012,213,2.16 [1.52-3.08],2.0338808399781483e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20539,104,1.11 [0.58-2.13],0.7517927194815581
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17754,72,2.19 [1.13-4.24],0.0204028088575419
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18751,4083,1.07 [0.96-1.19],0.2328620103705406
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17544,2876,1.06 [0.93-1.20],0.3807530868665387
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17748,66,1.88 [0.88-4.00],0.1008497205861213
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18077,122,2.03 [1.19-3.48],0.0094733066750466
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18075,120,1.47 [0.82-2.65],0.1948850732708698
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,20383,58,2.72 [1.34-5.54],0.0057284375318083
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18020,65,0.84 [0.36-1.96],0.6797661984155221
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15414,746,1.18 [0.92-1.52],0.2035962120567266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20457,127,0.85 [0.46-1.55],0.5942215804496762
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18180,225,1.23 [0.80-1.92],0.3470435165671884
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17499,5354,1.13 [1.03-1.24],0.0092547661133093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19667,85,1.48 [0.74-2.99],0.269941202574573
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17822,140,1.13 [0.64-1.98],0.6777351664726639
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,18068,386,1.07 [0.76-1.51],0.6996059118484598
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19843,1888,1.15 [0.99-1.34],0.0676015976371371
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,18002,320,1.14 [0.78-1.67],0.4916734391138861
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17729,47,1.15 [0.43-3.06],0.7818039185749649
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17768,86,1.09 [0.52-2.28],0.821318126205314
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,20285,27,0.30 [0.08-1.08],0.0647058404990236
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15902,1234,0.95 [0.78-1.16],0.6287584844421908
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15487,819,1.19 [0.94-1.51],0.1459845663911949
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20443,806,1.12 [0.89-1.41],0.3209198712564061
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14706,38,1.27 [0.42-3.90],0.6718816097008243
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14738,70,0.80 [0.35-1.84],0.6039987820059537
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17908,226,1.19 [0.76-1.86],0.443517017791201
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,15212,544,0.82 [0.61-1.10],0.1908969999557706
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17988,33,1.03 [0.31-3.38],0.9627484120415112
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18400,445,1.07 [0.78-1.47],0.6726723726171917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18176,221,1.20 [0.77-1.88],0.4181898840659875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,15175,507,0.83 [0.61-1.13],0.2434960533269992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17738,56,0.69 [0.27-1.71],0.4187927055485094
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17724,42,1.83 [0.73-4.62],0.2005074956417215
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19659,77,1.57 [0.78-3.17],0.2057166715343069
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20309,727,1.02 [0.80-1.31],0.8606280509136612
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19917,335,0.95 [0.65-1.38],0.7906520966999238
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20495,254,1.46 [0.99-2.17],0.0581925473676439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16279,1611,1.19 [1.00-1.41],0.0452081024290738
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14713,45,0.65 [0.23-1.82],0.4083841804219945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17749,67,1.34 [0.60-2.99],0.4711422846445666
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14718,50,1.99 [0.83-4.76],0.1227990615689457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14706,38,2.75 [1.07-7.05],0.0349552682637901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19740,158,1.29 [0.77-2.18],0.332796696792308
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19719,137,1.53 [0.89-2.64],0.1263768171221176
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20533,73,1.87 [0.94-3.74],0.0748293282415259
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19244,1289,1.24 [1.04-1.49],0.0192082843455675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17739,57,1.46 [0.62-3.44],0.3856804197325524
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14703,35,2.45 [0.93-6.48],0.0710589747241226
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18483,528,1.18 [0.88-1.57],0.2702846672220874
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16127,1459,1.14 [0.95-1.35],0.1567683175932377
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,20304,46,0.59 [0.22-1.59],0.2956739401283613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20548,55,1.22 [0.51-2.95],0.6513071894425964
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17754,72,1.70 [0.81-3.57],0.1604610544854096
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18510,828,1.32 [1.05-1.66],0.0159375132734149
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17759,77,1.57 [0.75-3.27],0.2273699646013537
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15708,1040,1.08 [0.88-1.34],0.4634871648001756
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19654,72,0.93 [0.42-2.07],0.8580169243978257
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17720,38,0.79 [0.26-2.42],0.6816106148491103
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18052,97,0.74 [0.37-1.47],0.3846717439039228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18101,419,1.19 [0.86-1.64],0.3025733981288994
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,20424,166,1.05 [0.62-1.76],0.8666571790635086
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18369,414,1.17 [0.84-1.61],0.3479022086386759
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20503,251,1.49 [1.00-2.21],0.0486560624497988
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20549,33,1.36 [0.45-4.14],0.5850872665371241
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17811,129,0.97 [0.54-1.77],0.9289255506831886
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16884,486,1.21 [0.90-1.63],0.2086489483252231
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,18080,398,1.39 [1.01-1.92],0.0452978876191177
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17971,289,1.21 [0.81-1.80],0.3592404573466529
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14694,26,1.05 [0.27-4.12],0.9389852894042924
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16606,1938,1.18 [1.01-1.37],0.0406329126739822
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15048,380,1.39 [0.99-1.97],0.0576193846887284
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,20397,139,0.96 [0.54-1.70],0.876433065889849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20497,37,2.66 [1.16-6.07],0.0202402616975126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18868,36,0.73 [0.24-2.23],0.5771996570837536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14725,57,1.33 [0.55-3.25],0.5292456408291526
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18031,76,0.89 [0.41-1.93],0.7601026420241711
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14929,261,1.61 [1.07-2.42],0.0210270830499751
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17933,251,1.41 [0.94-2.12],0.098497965866344
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18138,183,1.32 [0.82-2.12],0.2522676411608722
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18028,73,0.96 [0.43-2.11],0.9110429264400618
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16358,26,1.13 [0.30-4.20],0.8544056669634565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20550,34,1.76 [0.63-4.86],0.2786296760558465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,18138,456,1.51 [1.12-2.03],0.0074278443166266
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],20275,17,1.11 [0.23-5.43],0.9001320133400827
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19633,1951,1.24 [1.07-1.44],0.0050657707213296
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17772,90,1.57 [0.80-3.09],0.1906086470467007
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18374,419,1.18 [0.85-1.62],0.3172230692347853
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19643,172,1.06 [0.64-1.77],0.8182191127413023
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18073,118,1.56 [0.87-2.78],0.1321622469996159
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19069,1114,1.11 [0.91-1.35],0.3218004012052397
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18646,691,1.29 [1.00-1.65],0.0473876865854241
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17715,33,2.32 [0.93-5.77],0.0696398757455249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,20293,35,0.92 [0.29-2.88],0.879585129664643
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17790,108,1.10 [0.58-2.10],0.7730118542955565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17700,18,3.67 [1.47-9.13],0.0051941513031001
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14718,50,2.40 [0.97-5.96],0.0594125234871656
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19804,1541,1.41 [1.20-1.65],2.868066428505561e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,20156,343,0.88 [0.61-1.26],0.4841150787539651
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19937,124,0.83 [0.45-1.53],0.5603660571130604
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19419,1156,1.22 [1.01-1.48],0.0367333956127609
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,20361,49,1.17 [0.47-2.94],0.7305990182233029
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,20356,300,1.41 [0.98-2.03],0.0634140904593448
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cystitis,18152,180,1.38 [0.85-2.25],0.1914141777066242
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Dialysis,18329,66,0.81 [0.35-1.83],0.6065475479971572
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19486,2854,0.99 [0.87-1.12],0.878921301937665
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18597,4773,1.12 [1.01-1.23],0.0248011858812679
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,20387,75,1.17 [0.56-2.44],0.6776694707426641
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16811,179,0.93 [0.56-1.54],0.7739428275928549
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,18333,297,0.99 [0.67-1.47],0.9614192342133324
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18872,2240,0.97 [0.84-1.12],0.6559710251031383
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16830,198,1.49 [0.94-2.35],0.08850890680248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18035,63,0.91 [0.39-2.14],0.8258471093409309
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16727,95,1.39 [0.72-2.70],0.3299983499862121
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20555,55,2.20 [1.05-4.60],0.0369511120655027
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20555,46,1.54 [0.60-3.96],0.3701900319401089
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19859,1887,1.16 [0.99-1.35],0.0582449114647499
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18802,830,1.22 [0.96-1.53],0.097683898365502
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20506,450,1.18 [0.87-1.61],0.2847890684332257
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16896,264,0.62 [0.40-0.94],0.0247751941614775
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16877,245,1.35 [0.89-2.04],0.1588352239512714
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16827,195,0.79 [0.48-1.28],0.3376424748863745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20550,40,0.96 [0.34-2.75],0.9432996648720344
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19226,1254,1.36 [1.14-1.64],0.0008031567036913
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18369,333,1.06 [0.73-1.53],0.7708818047478698
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,20204,148,0.67 [0.38-1.17],0.1546152152998391
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,20367,55,0.76 [0.30-1.91],0.5618274685533546
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16863,231,1.43 [0.93-2.19],0.1020989557360132
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20347,2311,1.23 [1.07-1.40],0.0031599340104491
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18091,55,0.97 [0.39-2.38],0.9411422477293434
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18381,118,1.13 [0.61-2.07],0.7004729505520475
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19877,64,0.83 [0.36-1.93],0.6707069688867566
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18224,252,1.02 [0.67-1.56],0.9260050769342631
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,20261,448,0.94 [0.69-1.30],0.723191909284546
